Gossamer Bio stock has maintained its consensus analyst price target at $9.50 per share, even as analysts adjust their outlooks in response to the company's progress on key clinical milestones. A ...

Grab Eureka Forbes air purifiers at major discounts for a limited period. Strong filtration, lower prices, and fast-moving ...

Haryana-based MV Electrosystems, which manufactures electrical & power electronics equipments for railway rolling stock, has ...

Rupee weakness isn’t a concern for exporters, but October’s wider trade gap was driven by a spike in precious metals imports, ...

The North American Nucleic Acid Amplification Testing (NAAT) market will reach $7.64 billion by 2033, growing from $3.28 ...